Next Science Ltd (OTCPK:NXSCF)
$ 0.1496 -0.0329 (-18.03%) Market Cap: 47.70 Mil Enterprise Value: 39.39 Mil PE Ratio: 0 PB Ratio: 2.99 GF Score: 50/100

Half Year 2022 Next Science Ltd Earnings Call Transcript

Aug 25, 2022 / 12:00AM GMT
Release Date Price: $0.6376
Operator

Thank you for standing by, and welcome to the Next Science Limited 2022 Half Year Results Conference Call. (Operator Instructions)

And now I would like to hand the conference over to Ms. Judith Mitchell, Managing Director. Please go ahead.

Judith Mitchell
Next Science Limited - MD, CEO & Executive Director

Good morning, ladies and gentlemen, and thank you for joining the first half call for Next Science for the financial year of 2022. For those people who are not familiar with Next Science, we're a company that have a novel laser for the problems caused by biofilms and their ability to accelerate the issues that cause chronic infection. Our mission as a company is to use our XBIO technology platform to help resolve these issues and provide products to physicians to assist in healing people and saving lives.

Business is very pleased to report that for the first half of 2022, we delivered our strongest revenue to date for a first half, being USD 5.4 million. This result is 38% up on the prior first half of 2021 with product sales up 67%.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot